Sangamo Therapeutics
Sangamo Therapeutics, based in Brisbane, CA, is a pioneer in genomic medicine, utilizing its proprietary zinc finger technology to develop innovative genomic cures for severe diseases that currently offer limited treatment options. The company focuses on a range of therapeutic applications, including neurology and oncology, and is committed to translating groundbreaking scientific advancements into effective therapies.
With a robust pipeline and a commitment to clinical development, Sangamo is actively engaged in advancing treatments for various conditions, such as Fabry disease, hemophilia A, and prion disease, through both wholly owned and partnered programs. Their initiatives are aimed at providing patients with transformative therapies that address the underlying causes of their diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.